july 30 2007 endocrinologic and metabolic drugs advisory
play

July 30, 2007: Endocrinologic and Metabolic Drugs Advisory Committee - PowerPoint PPT Presentation

Oct 27, 2023 •407 likes •504 views

July 30, 2007: Endocrinologic and Metabolic Drugs Advisory Committee Meeting July 13 14, 2010: Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee September 15

  4. July 30, 2007: Endocrinologic and Metabolic Drugs Advisory Committee Meeting July 13 ‐ 14, 2010: Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee

  6. September 15 ‐ 16, 2010: Endocrinologic and Metabolic Drugs Advisory Committee Meeting

  7. FDA Officials Discuss FDA Actions

  8. NEJM Publication of Sentinel Findings Ad Hoc Sentinel Queries ‐ Online Only on FDA section of NEJM Health Policy Website ‐ Peer review: focused review, narrowly tailored to Sentinel information Planned Sentinel Evaluations ‐ Perspective articles or Special Reports ‐ Peer review: rapid review, 48 ‐ hour turnaround

Recommend

Endocrinologic and Metabolic Drugs Advisory Committee Meeting Gaithersburg, Maryland July 15,

Endocrinologic and Metabolic Drugs Advisory Committee Meeting Gaithersburg, Maryland July 15,

Endocrinologic and Metabolic Drugs Advisory Committee Meeting Gaithersburg, Maryland July 15, 2010 QNEXA (Phentermine/Topiramate) NDA 22580 Mary Dunne Roberts, MD Division of Metabolism and Endocrinology Products 1 Outline Efficacy

1.04k views • 87 slides
The cellular nucleotides, metabolic fatty acids, etc. machine Carbon Biomass/ source energy

The cellular nucleotides, metabolic fatty acids, etc. machine Carbon Biomass/ source energy

International Workshop on Complex Systems and International Workshop on Complex Systems and Networks 2007, Guilin Guilin, China , China Networks 2007, Metabolic Networks Metabolic Networks Organization, Biomass Production, and Other Issues

275 views • 16 slides
Company presentation June 2017 1 | Clinical stage company focusing on drugs for diseases of the

Company presentation June 2017 1 | Clinical stage company focusing on drugs for diseases of the

Company presentation June 2017 1 | Clinical stage company focusing on drugs for diseases of the central nervous system, autoimmune diseases and metabolic diseases 3 clinical stage candidates for obesity, metabolic diseases and cocaine

724 views • 25 slides
5 October 2007 AGM BIOTRON LIMITED Developing new generation antiviral drugs with large,

5 October 2007 AGM BIOTRON LIMITED Developing new generation antiviral drugs with large,

5 October 2007 AGM BIOTRON LIMITED Developing new generation antiviral drugs with large, expanding world markets. Current major focus on drugs to treat HIV-1 and Hepatitis C virus. 1 Biotron Limited RECENT KEY HIGHLIGHTS

360 views • 22 slides
Metabolic flux estimation So far in this course we have examined techniques that help us

Metabolic flux estimation So far in this course we have examined techniques that help us

Metabolic flux estimation So far in this course we have examined techniques that help us understanding the cells capabilities: Given genome, what kind of metabolic network (Metabolic reconstruction) Given metabolic network, what

347 views • 34 slides
Metabolic flux estimation So far in this course we have examined techniques that help us

Metabolic flux estimation So far in this course we have examined techniques that help us

Metabolic flux estimation So far in this course we have examined techniques that help us understanding the cells capabilities: Given genome, what kind of metabolic network (Metabolic reconstruction) Given metabolic network, what

938 views • 37 slides
Statewide High Speed Network networkMaryland Advisory Group Meeting July 17, 2007 Annapolis,

Statewide High Speed Network networkMaryland Advisory Group Meeting July 17, 2007 Annapolis,

Statewide High Speed Network networkMaryland Advisory Group Meeting July 17, 2007 Annapolis, Maryland Meeting Agenda Welcome & Introductions State of the Network Status of Project Other Business 2 Welcome Introductions

647 views • 27 slides
ACCMEs Member Organizations AC American Board of Medical Specialties American Hospital

ACCMEs Member Organizations AC American Board of Medical Specialties American Hospital

ACCME at the FDA Murray Kopelow MD July 22, 2010 ACCME Accredited Continuing Education as a Strategic Asset to REMS ACCME @ the Anesthetic and Life Support Drugs Advisory Committee and Drug Safety and Risk Advisory Committee and Drug Safety

313 views • 14 slides
Science Park Project Presentation Science Park Project Presentation Wolf Pen Creek Advisory Board

Science Park Project Presentation Science Park Project Presentation Wolf Pen Creek Advisory Board

Science Park Project Presentation Science Park Project Presentation Wolf Pen Creek Advisory Board July 24 2007 July 24, 2007 Eric Simanek k BCS Resident Iconic Features of BCS f Impacting the Quality of Life in BCS Education Entertainment

932 views • 45 slides
ISU Inter ernal nal Advisory y Board rd Meeting ing December 3, 2010 Grant No. 0653236, July

ISU Inter ernal nal Advisory y Board rd Meeting ing December 3, 2010 Grant No. 0653236, July

STEM Talent Expansion Program (STEP) STEM Student Enrollment and Engagement through Connections ISU Inter ernal nal Advisory y Board rd Meeting ing December 3, 2010 Grant No. 0653236, July 2007 July 2012 Click to edit Master title style

243 views • 13 slides
Organization and simplification of Organization and simplification of metabolic networks

Organization and simplification of Organization and simplification of metabolic networks

The 3rd KIAS Conference on Statistical Physics, Seoul, Korea, 1-4 July, 2008 Nonequilibrium Statistical Physics of Complex Systems Organization and simplification of Organization and simplification of metabolic networks metabolic networks

513 views • 18 slides
Scott D. Kelley, M.D. Vice President of Medical Affairs March 7, 2007 Anesthetic and Life

Scott D. Kelley, M.D. Vice President of Medical Affairs March 7, 2007 Anesthetic and Life

Scott D. Kelley, M.D. Vice President of Medical Affairs March 7, 2007 Anesthetic and Life Support Drugs Advisory Committee Food and Drug Administration; Department of Health and Human Services RE: Request for Formal Oral Presentation Public

517 views • 22 slides
STRUCTURE & FUNCTION OF METABOLIC NETWORKS Petter Holme KTH, CSC, Computational Biology

STRUCTURE & FUNCTION OF METABOLIC NETWORKS Petter Holme KTH, CSC, Computational Biology

introduction to complex networks metabolic networks STRUCTURE & FUNCTION OF METABOLIC NETWORKS Petter Holme KTH, CSC, Computational Biology Oktober 10, 2007, SBC seminar series http://www.csc.kth.se/ pholme/ Petter Holme STRUCTURE

1.14k views • 85 slides
GWA Advisory Committee GWA Advisory Committee July 11, 2018 July 11, 2018 Agenda Minimum

GWA Advisory Committee GWA Advisory Committee July 11, 2018 July 11, 2018 Agenda Minimum

GWA Advisory Committee GWA Advisory Committee July 11, 2018 July 11, 2018 Agenda Minimum Thresholds Projected Water Budget (Update on Assumptions) Hydrogeologic Conceptual Model Discussion Water Accounting Framework Approach

701 views • 49 slides
July 2016 July 2016 Prescription Form Security LSMS NHS England (South East) Controlled Drugs

July 2016 July 2016 Prescription Form Security LSMS NHS England (South East) Controlled Drugs

July 2016 July 2016 Prescription Form Security LSMS NHS England (South East) Controlled Drugs Local Intelligence Network www.tiaa.co.uk July 2016 Aim Our aim is to provide NHS staff that handle prescription forms with guidance and advice to

278 views • 23 slides
Integrating flux balance analysis of fungal genome-scale metabolic networks into metabolic

Integrating flux balance analysis of fungal genome-scale metabolic networks into metabolic

Integrating flux balance analysis of fungal genome-scale metabolic networks into metabolic engineering practice 2010 Pathway Tools Workshop Jim Collett Chemical and Biological Process Development Group Pacific Northwest National Laboratory

593 views • 40 slides
Science to cure and prevent metabolic syndrome Coporate Overview July 2018 Glaceum Inc. / 28

Science to cure and prevent metabolic syndrome Coporate Overview July 2018 Glaceum Inc. / 28

Science to cure and prevent metabolic syndrome Coporate Overview July 2018 Glaceum Inc. / 28 Philosophy - Holistic Approaches The ducks legs are short, but to stretch them out would worry him; the cranes legs are long, but to cut

116 views • 11 slides
Metabolic Pathways Networks of Care Professor Anne Green Lead Scientist Metabolic Biochemistry

Metabolic Pathways Networks of Care Professor Anne Green Lead Scientist Metabolic Biochemistry

Metabolic Pathways Networks of Care Professor Anne Green Lead Scientist Metabolic Biochemistry Network www.metbio.net Presentation to RCPath March 2006 National Metabolic Biochemistry Network National Metabolic Biochemistry Network

720 views • 36 slides
PROSPECTS FOR ALGAE ARI PATRINOS SYNTHETIC GENOMICS INC. Role of Metabolic Engineering in

PROSPECTS FOR ALGAE ARI PATRINOS SYNTHETIC GENOMICS INC. Role of Metabolic Engineering in

PROSPECTS FOR ALGAE ARI PATRINOS SYNTHETIC GENOMICS INC. Role of Metabolic Engineering in Industrial Biotechnology Targeted manipulation of metabolic pathways Products from metabolic engineering Ethanol 1,3-Propanediol

357 views • 15 slides
USING DATA TO IMPROVE METABOLIC SPECIFICITY AND CONDITIONING FOR TEAM SPORT ATHLETES Friday,

USING DATA TO IMPROVE METABOLIC SPECIFICITY AND CONDITIONING FOR TEAM SPORT ATHLETES Friday,

USING DATA TO IMPROVE METABOLIC SPECIFICITY AND CONDITIONING FOR TEAM SPORT ATHLETES Friday, July 17, 2015 TELL ME AND I FORGET, TEACH ME AND I MAY REMEMBER, INVOLVE ME AND I LEARN -BEN FRANKLIN Friday, July 17, 2015 A CALL FOR CHANGE

1.08k views • 107 slides
First Quarter FY08 Presented to District Energy Advisory Board November 15, 2007 Agenda 1.

First Quarter FY08 Presented to District Energy Advisory Board November 15, 2007 Agenda 1.

Advisory Board Quarterly Meeting First Quarter FY08 Presented to District Energy Advisory Board November 15, 2007 Agenda 1. Call to Order 2. Review and Approval of Meeting Minutes for August 16, 2007 3. Review and Comparison of DES Unit

562 views • 34 slides
R&D Day July 13, 2016 Ionis: Creating Value Three groundbreaking Phase 3 drugs Near-term

R&D Day July 13, 2016 Ionis: Creating Value Three groundbreaking Phase 3 drugs Near-term

R&D Day July 13, 2016 Ionis: Creating Value Three groundbreaking Phase 3 drugs Near-term close to commercialization Advanced, diverse pipeline of first-in- Mid-term class medicines of high value for patients with significant unmet medical

918 views • 35 slides
Drugs H O W T O K E E P O U R B O D I E S H E A L T H Y ! How can we keep our bodies

Drugs H O W T O K E E P O U R B O D I E S H E A L T H Y ! How can we keep our bodies

Just Say No! to Drugs H O W T O K E E P O U R B O D I E S H E A L T H Y ! How can we keep our bodies healthy? Getting exercise Eating lots of fruits and veggies Sleeping enough Saying no to drugs and alcohol What do

561 views • 18 slides
Drugs H O W T O K E E P O U R B O D I E S H E A L T H Y ! How can we keep our bodies

Drugs H O W T O K E E P O U R B O D I E S H E A L T H Y ! How can we keep our bodies

Just Say No! to Drugs H O W T O K E E P O U R B O D I E S H E A L T H Y ! How can we keep our bodies healthy? Getting exercise Eating lots of fruits and veggies Sleeping enough Saying no to drugs and alcohol What is

612 views • 14 slides

More recommend